These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 15466215)

  • 1. Haploid inactivation of the amplified-in-breast cancer 3 coactivator reduces the inhibitory effect of peroxisome proliferator-activated receptor gamma and retinoid X receptor on cell proliferation and accelerates polyoma middle-T antigen-induced mammary tumorigenesis in mice.
    Zhang H; Kuang SQ; Liao L; Zhou S; Xu J
    Cancer Res; 2004 Oct; 64(19):7169-77. PubMed ID: 15466215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H; Stephens LC; Kumar R
    Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis.
    Forrester E; Chytil A; Bierie B; Aakre M; Gorska AE; Sharif-Afshar AR; Muller WJ; Moses HL
    Cancer Res; 2005 Mar; 65(6):2296-302. PubMed ID: 15781643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of mammary tumorigenesis in transgenic mice by the RXR-selective retinoid, LGD1069.
    Wu K; Kim HT; Rodriquez JL; Hilsenbeck SG; Mohsin SK; Xu XC; Lamph WW; Kuhn JG; Green JE; Brown PH
    Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):467-74. PubMed ID: 12010861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The retinoid X receptor-selective retinoid, LGD1069, prevents the development of estrogen receptor-negative mammary tumors in transgenic mice.
    Wu K; Zhang Y; Xu XC; Hill J; Celestino J; Kim HT; Mohsin SK; Hilsenbeck SG; Lamph WW; Bissonette R; Brown PH
    Cancer Res; 2002 Nov; 62(22):6376-80. PubMed ID: 12438218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of the colony-stimulating factor (CSF-1) and/or its receptor c-fms in mammary glands of transgenic mice results in hyperplasia and tumor formation.
    Kirma N; Luthra R; Jones J; Liu YG; Nair HB; Mandava U; Tekmal RR
    Cancer Res; 2004 Jun; 64(12):4162-70. PubMed ID: 15205327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of peroxisome proliferator activated receptor mRNA in normal and tumorigenic rodent mammary glands.
    Gimble JM; Pighetti GM; Lerner MR; Wu X; Lightfoot SA; Brackett DJ; Darcy K; Hollingsworth AB
    Biochem Biophys Res Commun; 1998 Dec; 253(3):813-7. PubMed ID: 9918810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human invasive trophoblasts transformed with simian virus 40 provide a new tool to study the role of PPARgamma in cell invasion process.
    Pavan L; Tarrade A; Hermouet A; Delouis C; Titeux M; Vidaud M; Thérond P; Evain-Brion D; Fournier T
    Carcinogenesis; 2003 Aug; 24(8):1325-36. PubMed ID: 12807721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of adipocyte-specific gene expression is correlated with mammary tumor regression by the retinoid X receptor-ligand LGD1069 (targretin).
    Agarwal VR; Bischoff ED; Hermann T; Lamph WW
    Cancer Res; 2000 Nov; 60(21):6033-8. PubMed ID: 11085524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen promotes mammary tumor development in C3(1)/SV40 large T-antigen transgenic mice: paradoxical loss of estrogen receptoralpha expression during tumor progression.
    Yoshidome K; Shibata MA; Couldrey C; Korach KS; Green JE
    Cancer Res; 2000 Dec; 60(24):6901-10. PubMed ID: 11156389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer.
    Vasiljeva O; Papazoglou A; Krüger A; Brodoefel H; Korovin M; Deussing J; Augustin N; Nielsen BS; Almholt K; Bogyo M; Peters C; Reinheckel T
    Cancer Res; 2006 May; 66(10):5242-50. PubMed ID: 16707449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of peroxisome proliferator-activated receptor gamma and the growth inhibitory effect of its synthetic ligands in human salivary gland cancer cell lines.
    Begum NM; Nakashiro K; Kawamata H; Uchida D; Shintani S; Ikawa Y; Sato M; Hamakawa H
    Int J Oncol; 2002 Mar; 20(3):599-605. PubMed ID: 11836575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
    Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WAP-TAg transgenic mice and the study of dysregulated cell survival, proliferation, and mutation during breast carcinogenesis.
    Li M; Lewis B; Capuco AV; Laucirica R; Furth PA
    Oncogene; 2000 Feb; 19(8):1010-9. PubMed ID: 10713684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mice lacking the amplified in breast cancer 1/steroid receptor coactivator-3 are resistant to chemical carcinogen-induced mammary tumorigenesis.
    Kuang SQ; Liao L; Wang S; Medina D; O'Malley BW; Xu J
    Cancer Res; 2005 Sep; 65(17):7993-8002. PubMed ID: 16140972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor alpha in the human breast cancer cell lines MCF-7 and MDA-MB-231.
    Suchanek KM; May FJ; Robinson JA; Lee WJ; Holman NA; Monteith GR; Roberts-Thomson SJ
    Mol Carcinog; 2002 Aug; 34(4):165-71. PubMed ID: 12203367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligands for the peroxisome proliferator-activated receptor-gamma and the retinoid X receptor-alpha exert synergistic antiproliferative effects on human coronary artery smooth muscle cells.
    Benson S; Padmanabhan S; Kurtz TW; Pershadsingh HA
    Mol Cell Biol Res Commun; 2000 Mar; 3(3):159-64. PubMed ID: 10860864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of Tip30 leads to rapid immortalization of murine mammary epithelial cells and ductal hyperplasia in the mammary gland.
    Pecha J; Ankrapp D; Jiang C; Tang W; Hoshino I; Bruck K; Wagner KU; Xiao H
    Oncogene; 2007 Nov; 26(53):7423-31. PubMed ID: 17533366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPARgamma influences susceptibility to DMBA-induced mammary, ovarian and skin carcinogenesis.
    Nicol CJ; Yoon M; Ward JM; Yamashita M; Fukamachi K; Peters JM; Gonzalez FJ
    Carcinogenesis; 2004 Sep; 25(9):1747-55. PubMed ID: 15073042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SV40 small t-antigen prevents mammary gland differentiation and induces breast cancer formation in transgenic mice; truncated large T-antigen molecules harboring the intact p53 and pRb binding region do not have this effect.
    Goetz F; Tzeng YJ; Guhl E; Merker J; Graessmann M; Graessmann A
    Oncogene; 2001 Apr; 20(18):2325-32. PubMed ID: 11402328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.